Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pantoprazole pharmacokinetics and pharmacodynamics in neonates and preterm infants with presumed GERD
2006-001473-24Phase 3Completed
- Sponsor
- Wyeth
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of pantoprazole in gastroesophageal reflux disease (GERD), sponsored by Wyeth. Primary endpoints: Clinical Symptoms Evaluation and Pharmacokinetic parameters. Started May 2006; status: completed.
02
Drugs
pantoprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on 2006-001473-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001473-24.